MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dementia with Lewy bodies (DLB)"

  • 2019 International Congress

    Prodromal symptoms in clinically diagnosed dementia with Lewy bodies stratified by Lewy body pathology on autopsy

    K. Wyman-Chick, D. Weintraub, M. Rosenbloom, L. Erickson, P. Martin, T. Barclay, M. Barrett (Bloomington, MN, USA)

    Objective: Compare prodromal neuropsychiatric, sleep, and motor symptoms in patients clinically diagnosed with dementia with Lewy bodies (DLB) with and without Lewy body pathology on…
  • 2019 International Congress

    Cortical FDG-PET patterns predict long-term motor progression and disability milestones in Parkinson’s disease

    A. Pilotto, A. Imarisio, E. Premi, SP. Caminiti, L. Presotto, A. Sala, R. Turrone, R. Grasso, A. Alberici, B. Paghera, MC. Rizzetti, B. Borroni, D. Perani, A. Padovani (Brescia, Italy)

    Objective: To evaluate the accuracy of single-subject FDG-PET in predicting motor and cognitive long-term progression in Parkinson's disease Background: The progression of Parkinson's disease is…
  • 2019 International Congress

    Functional connectivity and microstructural alterations in regions of synaptic density loss in DLB and PDD

    T. Yousaf, G. Dervenoulas, G. Pagano, C. Loane, H. Wilson, A. Chandra, O. Cousins, R. Gunn, E. Rabiner, F. Niccolini, M. Esposito, L. Ricciardi, D. Aarsland, M. Politis (London, United Kingdom)

    Objective: We aimed to investigate whether functional connectivity and white matter integrity is altered in regions exhibiting reduced synaptic density, as measured by [11C]UCB-J-PET,in Dementia with…
  • 2019 International Congress

    A Lewy body disease of widely confirmed Lewy bodies in the cerebral cortexes including the occipital lobe without pathological changes in the hippocampal CA2/3 region

    M. Ryo, K. Hasegawa, I. Saitoh, S. Yagishita (Tokyo, Japan)

    Objective: We present Lewy body disease (LBD) showing unique neuropathological findings which are widely recognized Lewy bodies (LBs) in the cerebral cortexes including the occipital…
  • 2019 International Congress

    Visual hallucinations in Lewy Body Disease are characterised by impaired sensory integration

    A. Zarkali, R. Adams, L. Leyland, G. Rees, R. Weil (London, United Kingdom)

    Objective: To test whether increased reliance on prior knowledge is associated with visual hallucinations in Lewy Body Disease (LBD: Parkinson’s disease and Dementia with Lewy…
  • 2019 International Congress

    Increased lysosphingolipids levels in blood of patients with multiple system atrophy

    K. Senkevich, G. Baydakova, A. Emelyanov, M. Nikolaev, A. Kopytova, I. Miliukhina, E. Gracheva, A. Kudrevatykh, I. Krasakov, L. Khublarova, I. Fursova, Y. Irishina, N. Zalutskaya, Y. Beltseva, E. Zakharova, S. Pchelina (Saint-Petersburg, Russian Federation)

    Objective: To estimate activity of lysosomal enzymes and lysosphingolipids concentration in dry blood spot of patients with synuleinopathies: Parkinson’s disease (PD), dementia with Lewy bodies…
  • 2019 International Congress

    Patterns of Lewy body dementia diagnosis and treatment in Florida

    M. Armstrong, R. Eisinger, C. Garvan, B. Patel (Gainesville, FL, USA)

    Objective: To characterize the demographic and treatment characteristics for the Lewy body dementia (LBD) population in Florida using a statewide clinical data research network. Background:…
  • 2019 International Congress

    The frequency and impact of mutations in the GBA gene and APOε4 polymorphisms on the clinical features of Dementia with Lewy Bodies among Ashkenazi Jews

    T. Shiner, A. Mirelman, Y. Rozenblum, G. Kave', M. Gana Weisz, A. Bar-Shira, A. Thaler, R. Shahar, T. Gurevich, A. Orr-Urtreger, N. Giladi, N. Bregman (Tel Aviv, Israel)

    Objective: We aimed to explore the frequency and clinical impact of GBA mutations and APOε4 polymorphisms in a cohort of Ashkenazi Jewish (AJ) patients with…
  • 2019 International Congress

    Extrastriatal dopaminergic and serotonergic pathways in Parkinson’s disease and in dementia with Lewy bodies: a 123I-FP-CIT study

    A. Pilotto, F. Schianodicola, E. Premi, R. Grasso, R. Turrone, S. Gipponi, A. Scalvini, E. Cottini, B. Pagherà, V. Garibotto, MC. Rizzetti, L. Bonanni, B. Borroni, S. Morbelli, F. Nobili, UP. Guerra, D. Perani, A. Padovani (Brescia, Italy)

    Objective: To evaluate the common and divergent dopaminergic and serotonergic impairment in Parkinson's disease and dementia with Lewy bodies using 123I-FP-CIT imaging. Background: Striatal dopaminergic…
  • 2019 International Congress

    Alpha-synuclein expression and cytokine profile in blood of patients with Lewy body dementias

    T. Usenko, M. Nikolaev, A. Bezroukova, A. Emelyanov, E. Gracheva, I. Milukhina, Y. Belceva, N. Zalutskaya, A. Timofeeva, S. Pchelina (Gatchina, Russian Federation)

    Objective: To examine alpha-synuclein expression in CD45+ and cytokine levels in blood of patients with dementia with Lewy bodies (DLB), Parkinson's disease dementia (PDD). Background:…
  • « Previous Page
  • 1
  • …
  • 16
  • 17
  • 18
  • 19
  • 20
  • …
  • 25
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley